2023 Q4 Form 10-Q Financial Statement

#000143774923031613 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $684.0K $368.0K
YoY Change 19.16% -38.56%
Cost Of Revenue $1.405M $692.0K
YoY Change 55.42% -40.5%
Gross Profit -$721.0K -$324.0K
YoY Change 118.48% -42.55%
Gross Profit Margin -105.41% -88.04%
Selling, General & Admin $4.419M $5.130M
YoY Change -0.27% 36.07%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $307.0K $310.0K
YoY Change 69.61% 72.22%
% of Gross Profit
Operating Expenses $4.724M $5.440M
YoY Change 2.43% 40.21%
Operating Profit -$5.445M -$5.759M
YoY Change 10.18% 29.59%
Interest Expense -$1.307M $1.173M
YoY Change -38.32% -44.06%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.752M -$6.932M
YoY Change -4.38% 5.98%
Income Tax $3.000K $4.000K
% Of Pretax Income
Net Earnings -$8.043M -$6.936M
YoY Change -1.19% 5.97%
Net Earnings / Revenue -1175.88% -1884.78%
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$0.12 -$0.12
COMMON SHARES
Basic Shares Outstanding 66.71M 66.60M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.502M $13.30M
YoY Change -54.97% 91.17%
Cash & Equivalents $4.502M $13.31M
Short-Term Investments
Other Short-Term Assets $508.0K $800.0K
YoY Change -74.4% -61.52%
Inventory $2.106M $2.128M
Prepaid Expenses
Receivables $904.0K $410.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $8.020M $16.63M
YoY Change -35.5% 67.65%
LONG-TERM ASSETS
Property, Plant & Equipment $87.22M $85.54M
YoY Change 3.66% 5.9%
Goodwill $5.714M $5.714M
YoY Change 0.25% 49.86%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.438M $5.562M
YoY Change 8.11% 23.33%
Total Long-Term Assets $99.35M $97.83M
YoY Change 1.02% 3.85%
TOTAL ASSETS
Total Short-Term Assets $8.020M $16.63M
Total Long-Term Assets $99.35M $97.83M
Total Assets $107.4M $114.5M
YoY Change -3.08% 9.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.245M $1.626M
YoY Change 12.47% 251.95%
Accrued Expenses $1.170M $1.184M
YoY Change -24.27% 30.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $182.0K $193.0K
YoY Change 30.0% 30.41%
Total Short-Term Liabilities $5.835M $5.930M
YoY Change 3.48% 113.16%
LONG-TERM LIABILITIES
Long-Term Debt $37.71M $37.39M
YoY Change -22.96% -22.66%
Other Long-Term Liabilities $41.00K $39.00K
YoY Change 13.89% 11.43%
Total Long-Term Liabilities $37.75M $37.43M
YoY Change -22.93% -22.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.835M $5.930M
Total Long-Term Liabilities $37.75M $37.43M
Total Liabilities $67.41M $66.80M
YoY Change -11.96% -7.46%
SHAREHOLDERS EQUITY
Retained Earnings -$639.9M -$631.8M
YoY Change 6.06% 6.16%
Common Stock $665.0K $664.0K
YoY Change 19.6% 31.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $39.97M $47.66M
YoY Change
Total Liabilities & Shareholders Equity $107.4M $114.5M
YoY Change -3.08% 9.92%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$8.043M -$6.936M
YoY Change -1.19% 5.97%
Depreciation, Depletion And Amortization $307.0K $310.0K
YoY Change 69.61% 72.22%
Cash From Operating Activities -$5.524M -$5.530M
YoY Change 5.72% -5.05%
INVESTING ACTIVITIES
Capital Expenditures $1.967M $610.0K
YoY Change 108.37% -189.18%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$1.967M -$610.0K
YoY Change 23.79% -10.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.315M -1.080M
YoY Change -115.31% 1.79%
NET CHANGE
Cash From Operating Activities -5.524M -5.530M
Cash From Investing Activities -1.967M -610.0K
Cash From Financing Activities -1.315M -1.080M
Net Change In Cash -8.806M -7.220M
YoY Change -596.11% -4.62%
FREE CASH FLOW
Cash From Operating Activities -$5.524M -$5.530M
Capital Expenditures $1.967M $610.0K
Free Cash Flow -$7.491M -$6.140M
YoY Change 21.43% 19.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4444000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
2097000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6541000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6545000 usd
CY2022Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1265000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7810000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Operating Income Loss
OperatingIncomeLoss
-11620000 usd
us-gaap Interest Expense
InterestExpense
6144000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17764000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-171000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17940000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3818000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21758000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
329
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
329
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
329
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
329
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
85000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66604981
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66604981
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55823810
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55823810
CY2023Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
550
CY2023Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2023Q2 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
560
CY2023Q3 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2023Q3 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
550
CY2022Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2022Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
550
CY2022Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2022Q2 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
560
CY2022Q3 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2022Q3 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
550
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66604981
CY2013Q1 cdzi Number Of Milestones For Common Stock Issuance
NumberOfMilestonesForCommonStockIssuance
2 pure
CY2013Q1 cdzi Shares Payable Term From Date Earned
SharesPayableTermFromDateEarned
P3Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-12114
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0313235
dei Entity Address Address Line1
EntityAddressAddressLine1
550 South Hope Street, Suite 2850
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90071
dei City Area Code
CityAreaCode
213
dei Local Phone Number
LocalPhoneNumber
271-1600
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66710795
CY2023Q3 us-gaap Revenues
Revenues
368000 usd
CY2022Q3 us-gaap Revenues
Revenues
599000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
692000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1163000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5127000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3700000 usd
CY2023Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
308000 usd
CY2022Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
180000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
6127000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
5043000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5759000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1173000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6932000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6936000 usd
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1265000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8201000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
66611000
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
50793000
us-gaap Revenues
Revenues
1307000 usd
us-gaap Revenues
Revenues
927000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1482000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1163000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14378000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10911000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
942000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
473000 usd
us-gaap Costs And Expenses
CostsAndExpenses
16802000 usd
us-gaap Costs And Expenses
CostsAndExpenses
12547000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15495000 usd
us-gaap Interest Expense
InterestExpense
3637000 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
220000 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
-0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5331000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24683000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-24691000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3818000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28509000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65299000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
48689000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13306000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9997000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
410000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
454000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2128000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
316000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
782000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
380000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
16626000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
12435000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85536000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84138000 usd
CY2023Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
420000 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
420000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
5714000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5714000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
463000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
553000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
134000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2497000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5562000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5030000 usd
CY2023Q3 us-gaap Assets
Assets
114455000 usd
CY2022Q4 us-gaap Assets
Assets
110787000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1626000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1107000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1184000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1545000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
193000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
140000 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
1265000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1288000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1450000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1450000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
93000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
119000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5930000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5639000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
37394000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
48950000 usd
CY2023Q3 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
22333000 usd
CY2022Q4 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
20745000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
354000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
444000 usd
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
36000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
66800000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
76564000 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
664000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
556000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
678796000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
636963000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-631807000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-603298000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
47655000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34223000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114455000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110787000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24691000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17940000 usd
us-gaap Depreciation
Depreciation
942000 usd
us-gaap Depreciation
Depreciation
473000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
337000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1777000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
90000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
18000 usd
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
711000 usd
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
0 usd
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
1570000 usd
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
1390000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
220000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-5331000 usd
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-0 usd
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
0 usd
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
171000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1142000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1348000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-44000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
276000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1812000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
335000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
402000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
43000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
532000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
214000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1312000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
253000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-80000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-98000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
93000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
323000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
102000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15402000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13374000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3815000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2432000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
-0 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
101000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3815000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2533000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
38490000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
11741000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
233000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
275000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
3841000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
3841000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15119000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
117000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
27000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
600000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
-0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
261000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18875000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8058000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-342000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7849000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13782000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19856000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13440000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12007000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34223000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
65000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38490000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1265000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13782000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-10691000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
60822000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
164000 usd
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1288000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7064000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
52634000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
652000 usd
CY2023Q3 cdzi Adjustments To Additional Paid In Capital Reclassification Of Derivative Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfDerivativeLiability
2570000 usd
CY2023Q3 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1265000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-6936000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
47655000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40609000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
433000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11741000 usd
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1265000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5912000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
45606000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
423000 usd
CY2022Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1288000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5483000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
39258000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
491000 usd
CY2022Q3 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1265000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-6545000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
31939000 usd
us-gaap Net Income Loss
NetIncomeLoss
-24700000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17900000 usd
CY2023Q3 cdzi Working Capital
WorkingCapital
10700000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15400000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5300000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13306000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9997000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6957000 usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1265000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
134000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2497000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3785000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13440000 usd
CY2023Q3 us-gaap Assets
Assets
114455000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12007000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2023Q3 us-gaap Revenues
Revenues
368000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
692000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5127000 usd
CY2023Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
308000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
6127000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5759000 usd
us-gaap Revenues
Revenues
1307000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1482000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14378000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
942000 usd
us-gaap Costs And Expenses
CostsAndExpenses
16802000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15495000 usd
CY2022Q4 us-gaap Assets
Assets
110787000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
5714000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5714000 usd
CY2021Q2 cdzi Water Supply Agreement Number Of Acrefeet Of Water Per Annum To Customer
WaterSupplyAgreementNumberOfAcrefeetOfWaterPerAnnumToCustomer
9500 pure
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
652000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
492000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1142000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1348000 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5534000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2033000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5237000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1702000
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1450000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
2350000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
130000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3670000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-350000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4020000 usd
CY2023Q3 cdzi Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassification
2570000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1450000 usd
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
11500000 usd
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
11500000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1450000 usd
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1450000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
85000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66604981
CY2013Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
400000
CY2013Q1 cdzi Percentage Of Projects Annual Capacity
PercentageOfProjectsAnnualCapacity
0.51 pure
us-gaap Payments Of Dividends
PaymentsOfDividends
10396000 usd

Files In Submission

Name View Source Status
cdzi-20230930_cal.xml Edgar Link unprocessable
0001437749-23-031613-index-headers.html Edgar Link pending
0001437749-23-031613-index.html Edgar Link pending
0001437749-23-031613.txt Edgar Link pending
0001437749-23-031613-xbrl.zip Edgar Link pending
cdzi-20230930.xsd Edgar Link pending
cdzi20230930_10q.htm Edgar Link pending
ex_595484.htm Edgar Link pending
ex_595485.htm Edgar Link pending
ex_595486.htm Edgar Link pending
ex_595487.htm Edgar Link pending
ex_595488.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
cdzi-20230930_def.xml Edgar Link unprocessable
cdzi-20230930_lab.xml Edgar Link unprocessable
cdzi-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cdzi20230930_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending